Tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas: a rare adverse effect

BMJ Case Rep. 2017 Jun 18:2017:bcr2017219883. doi: 10.1136/bcr-2017-219883.

Abstract

A 53-year-old man with a history of Crohn's disease on infliximab, presented with several weeks of cough and dyspnoea. He had a right-sided pleural effusion, found to be exudative with lymphocytic predominance. He underwent right-sided video-assisted thoracic surgery (VATS) with biopsies and pleurodesis. Histopathology showed pleural-based non-caseating granulomas with unremarkable lung parenchyma. Cultures were only positive for Propionibacterium acnes 8 months later, he was found to have a left-sided exudative, lymphocytic predominant pleural effusion. Left-sided VATS and biopsies again showed pleural-based non-caseating granulomas with normal lung parenchyma. Having ruled out an active infection and malignant lesions, we diagnosed infliximab-induced pleural granulomas. Infliximab was stopped. The patient continues to do well at 6 years of follow-up. We believe this is the first report of tumour necrosis factor (TNF) inhibitor-induced isolated pleural granulomas. P. acnes and cytokine imbalance might be responsible for the pathogenesis of TNF inhibitor-induced granulomas.

Keywords: Crohn's disease; Gastrointestinal system; Respiratory medicine.

Publication types

  • Case Reports

MeSH terms

  • Cough
  • Crohn Disease / drug therapy*
  • Dyspnea
  • Gastrointestinal Agents / adverse effects*
  • Gastrointestinal Agents / therapeutic use
  • Gram-Positive Bacterial Infections / chemically induced*
  • Gram-Positive Bacterial Infections / physiopathology
  • Gram-Positive Bacterial Infections / therapy
  • Granuloma / chemically induced*
  • Granuloma / physiopathology
  • Granuloma / therapy
  • Humans
  • Infliximab / adverse effects*
  • Infliximab / therapeutic use
  • Male
  • Middle Aged
  • Pleural Effusion / chemically induced*
  • Pleural Effusion / physiopathology
  • Pleural Effusion / therapy
  • Pleurodesis
  • Propionibacterium acnes / isolation & purification
  • Thoracic Surgery, Video-Assisted
  • Time Factors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Gastrointestinal Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab